Fierce Biotech: "Building on Work with Lilly, Novartis and Pfizer, EHR-Trial Matching Tool Nears Market"

We rebanded today and Fierce Biotech told the story of where we've been and where we're going. 

"Antidote, the clinical trial tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ electronic health records (EHRs) to clinical trials. The product builds on a collaboration with Eli Lilly ($LLY), Novartis ($NVS) and Pfizer ($PFE) to structure eligibility criteria and data."

Read more on FierceBiotech.